Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
Phase of Trial: Phase IV
Latest Information Update: 25 Oct 2014
At a glance
- Drugs Pramipexole (Primary)
- Indications Restless legs syndrome
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2013 Planned end date changed from 1 Jun 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 25 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.